Hot Stocks To Buy Right Now

Earlier this week, the third-quarter GDP for the U.S. was raised from 3.2% to 3.5%, further demonstrating that the U.S. economy is on the mend. Existing home sales also hit a level last seen in 2007.

Source: Paul L Dineen via Flickr (Modified)

These are very encouraging signs that the U.S. economy is finally getting back on its feet. And considering a Republican dominated Congress and White House, change to help boost that economy should also come at a faster pace.

Hot Stocks To Buy Right Now: GlycoMimetics, Inc.(GLYC)

Advisors’ Opinion:

  • [By Lisa Levin]

    GlycoMimetics Inc (NASDAQ: GLYC) shares were also up, gaining 24 percent to $17.74 as the company issued an update on survival rates for its Phase 1/2 trial for GMI-1271.

  • [By Chris Lange]

    GlycoMimetics Inc. (NASDAQ: GLYC) saw its shares surge following positive mid-stage results from its GMI-1271. Previously at the American Society of Clinical Oncology (ASCO), GMI-1271 failed to impress, but with these most recent results a few analysts are taking notice. Jefferies raised its price target to $18 from $15, Stifel to $23 from $17 and SunTrust RobinsonHumphrey to $32 from $21. Shares were last seen trading up about 25% to $17.87, with a consensus price target of $19.50 and a 52-week range of $3.82 to $18.25.

Hot Stocks To Buy Right Now: LendingClub Corporation(LC)

Advisors’ Opinion:

  • [By Lisa Levin]

    LendingClub Corp (NYSE: LC) shares dropped 14 percent to $3.66 following weak Q4 and FY18 guidance.

    Shares of Duluth Holdings Inc (NASDAQ: DLTH) were down 16 percent to $16.20 after the company posted downbeat Q3 results.

  • [By Mark Balson]

    Lending Club’s (LC) acting CEO Scott Sanborn replies to company’s investors and assures that company is in strong financial position and enough cash flow in balance sheet. “Cash and securities amount to $868 million.” He replies.

    Scott Sanborn also ensured company’s investors through e-mail who buys company’s loans, “We plan to be around for many years.”

    But as per company’s website Leading Club’s loan investors, “May not receive full amount, if it goes out of business.” Or could see delayed payments. 

Hot Stocks To Buy Right Now: Golden Star Resources Ltd(GSS)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Golden Star (NYSEMKT: GSS) is a gold mining and exploration company, and operates gold mines in Ghana, West Africa. GSS is up 396% YTD after it announced in July that it had begun pre-commercial production of gold in an underground mine in Ghana. GSS is trading at $0.825 per share on Monday intraday.

Hot Stocks To Buy Right Now: Celldex Therapeutics Inc(CLDX)

Advisors’ Opinion:

  • [By Todd Campbell]

    The ability to develop game-changing new drugs that revolutionize patient care could cause shares in Axovant Sciences (NYSE:AXON), Celldex Therapeutics (NASDAQ:CLDX), and Esperion Therapeutics (NASDAQ:ESPR) to soar. However, success may be tough to come by, and that makes investing in these stocks a boom or bust proposition.

  • [By WWW.KIPLINGER.COM]

    Celldex Therapeutics, Inc. (CLDX) is the first of the major biotech stocks scheduled to release an update on a pretty important drug this quarter; look for news on Oct. 8 concerning melanoma treatment glembatumumab vedotin. And thats a firm date too. Celldex is slated to present an update on the therapy at the European Society for Medical Oncology Congress.

  • [By Lisa Levin]

    In trading on Tuesday, healthcare shares fell by 0.57 percent. Meanwhile, top losers in the sector included Amicus Therapeutics, Inc. (NASDAQ: FOLD), down 9 percent, and Celldex Therapeutics, Inc. (NASDAQ: CLDX), down 9 percent.

Hot Stocks To Buy Right Now: National Health Investors, Inc.(NHI)

Advisors’ Opinion:

  • [By Monica Gerson]

    National Health Investors Inc (NYSE: NHI) is expected to post its quarterly earnings at $1.17 per share on revenue of $57.82 million.

    Berkshire Hathaway Inc. (NYSE: BRK.B) is projected to post its quarterly earnings at $1.75 per share.

Leave a Reply

Your email address will not be published. Required fields are marked *